Variant ID: 1-55521770-C-T


This variant was identified in 1 publication

View GRCh38 version.


In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.

Arteriosclerosis, Thrombosis, And Vascular Biology
Chadwick, Alexandra C AC; Wang, Xiao X; Musunuru, Kiran K
Publication Date: 2017-09

Variant appearance in text: PCSK9: Q302X
PubMed Link: 28751571
Variant Present in the following documents:
  • Main text
View BVdb publication page